* CareDx Inc CDNA.OQ CDNA.O is expected to show a fall
in
quarterly revenue when it reports results on August 8.
* The Brisbane California California-based company is
expected to
report a 23.4% decrease in revenue to $61.764 million from
$80.63 million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for CareDx Inc is for a
loss
of 31 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for CareDx Inc
is
$10.5, below its last closing price of $11.10.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 -0.10 -0.11 -0.11 Met -1.9
Dec. 31 2023 -0.08 -0.09 -0.07 Beat 18.8
Sep. 30 2022 -0.14 -0.14 -0.06 Beat 57.1
Jun. 30 2022 -0.11 -0.11 -0.13 Missed -16.1
Mar. -0.05 -0.05 -0.13 Missed -160
31 2022
Dec. 31 2021 0.02 0.03 -0.03 Missed -192.3
Sep. 30 2021 0.01 0.01 0.07 Beat 483.3
Jun. 30 2021 0.05 0.05 0.11 Beat 111.5
This summary was machine generated August 5 at 02:07 GMT. All
figures in US dollars unless otherwise stated